ScholarIQanswers from OpenAlex & ORCID
Georgina V. Long
ResearcherPublications, citations & collaboration network
Georgina V. Long is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Georgina V. Long have?
ScholarIQindexed works
Georgina V. Long has 1,820 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Georgina V. Long have?
ScholarIQcitation count
Georgina V. Long has 170,498 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Georgina V. Long?
ScholarIQh-index
Georgina V. Long has an h-index of 169 in OpenAlex.
What is the i10-index of Georgina V. Long?
ScholarIQi10-index
Georgina V. Long has an i10-index of 654 in OpenAlex.
What is the ORCID of Georgina V. Long?
ScholarIQorcid
The ORCID for Georgina V. Long is on the source record.
What is the OpenAlex record for Georgina V. Long?
ScholarIQopenalex
The OpenAlex for Georgina V. Long is on the source record.
What are the most-cited papers on Georgina V. Long?
ScholarIQmost cited works
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Michele Maio, Alfonsus Johannes Maria van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Nageatte Ibrahim, Sandrine Marréaud, Alexander C. J. van Akkooi, Stefan Suciu, Caroline Robert
Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M. Woo, Tunç Iyriboz, Darragh Halpenny, Jane Cunningham, Jamie E. Chaft, Neil H. Segal, Margaret K. Callahan, Alexander M. Lesokhin, Jonathan E. Rosenberg, Martin H. Voss, Charles M. Rudin, Hira Rizvi, Xue Hou, Katherine Rodríguez, Melanie Albano, Ruth-Ann Gordon, Charles Leduc, Natasha Rekhtman, Bianca Harris, Alexander M. Menzies, Alexander Guminski, Matteo S. Carlino, Benjamin Y. Kong, Jedd D. Wolchok, Michael A. Postow, Georgina V. Long, Matthew D. Hellmann
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander Guminski, Michael P. Brown, James S. Wilmott, Jarem Edwards, Maria Gonzalez, Richard A. Scolyer, Alexander M. Menzies, Grant A. McArthur
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Georgina V. Long, Reinhard Dummer, Omid Hamid, Thomas F. Gajewski, Christian Caglevic, Stéphane Dalle, Ana Arance, Matteo S. Carlino, Jean‐Jacques Grob, Tae Min Kim, Lev Demidov, Caroline Robert, James Larkin, James R. Anderson, Janet Maleski, Mark M. Jones, Scott J. Diede, Tara C. Mitchell
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Alexander M. Menzies, Douglas B. Johnson, Sangeetha Ramanujam, Victoria Atkinson, Annie Wong, John Park, Jennifer L. McQuade, Alexander N. Shoushtari, Katy K. Tsai, Zeynep Eroglu, Oliver Klein, Jessica C. Hassel, Jeffrey A. Sosman, Alexander Guminski, Ryan J. Sullivan, Antoni Ribas, Matteo S. Carlino, Michael A. Davies, Shahneen Sandhu, Georgina V. Long